Please Wait

Applying Filters...

Desonide
USDMF
Table View

Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

Desonide

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

17 API Suppliers, 8 USDMF, 1 EU WC, 9 NDC API, 13 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

53 FDF Dossiers, 26 FDA Orange Book, 17 Europe, 2 Canada, 1 South Africa, 7 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 0.05%, OINTMENT;TOPICAL - 0.05%, GEL;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 2 DKSH, 1 Faran Shimi Pharmaceutical, 6 Nanjing Well Pharmaceutical, 4 Actylis, 19 BASF, 1 Finar, 4 Gangwal Chemicals, 6 Kerry, 4 Microlex e.U, 2 Pluviaendo, 4 Roquette, 5 Seppic, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

27 Topical, 13 Solubilizers, 11 Emulsifying Agents, 9 Coating Systems & Additives, 9 Film Formers & Plasticizers, 8 Surfactant & Foaming Agents, 8 Thickeners and Stabilizers, 6 Parenteral, 6 Lubricants & Glidants, 5 Co-Processed Excipients, 5 Granulation, 4 Fillers, Diluents & Binders, 3 Direct Compression, 2 Taste Masking, 2 Controlled & Modified Release, 1 API Stability Enhancers

DIGITAL CONTENT

15 News #PharmaBuzz

15 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 22 Regulatory FDF Prices

MARKET PLACE

7 APIs

7 APIs

PATENTS & EXCLUSIVITIES

3 US Patents, 1 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 USP, 2 Others

$ Xls download

Filters

Log in to access your PharmaMiles and download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
28/03/2025	Axplora	Germany	FARMABIOS SPA	19574	DESONIDE DRUG SUBSTANCE	2006-07-06	Active	II	Complete	2014-09-05	2014-09-03
28/03/2025	Aarti Pharmalabs	India	AARTI PHARMALABS LTD	22963	DESONIDE	2009-07-20	Active	II	N/A

Contact us
to update this info

Desonide

Desonide

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

17 API Suppliers

8 USDMF

1 EU WC

9 NDC API

13 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

53 FDF Dossiers

26 FDA Orange Book

17 Europe

2 Canada

1 South Africa

7 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 0.05%

OINTMENT;TOPICAL - 0.05%

GEL;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 Minakem

2 DKSH

1 Faran Shimi Pharmaceutical

6 Nanjing Well Pharmaceutical

4 Actylis

19 BASF

1 Finar

4 Gangwal Chemicals

6 Kerry

4 Microlex e.U

2 Pluviaendo

4 Roquette

5 Seppic

1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

27 Topical

13 Solubilizers

11 Emulsifying Agents

9 Coating Systems & Additives

9 Film Formers & Plasticizers

8 Surfactant & Foaming Agents

8 Thickeners and Stabilizers

6 Parenteral

6 Lubricants & Glidants

5 Co-Processed Excipients

5 Granulation

4 Fillers, Diluents & Binders

3 Direct Compression

2 Taste Masking

2 Controlled & Modified Release

1 API Stability Enhancers

DIGITAL CONTENT

15 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions

22 Regulatory FDF Prices

MARKET PLACE

7 APIs

PATENTS & EXCLUSIVITIES

3 US Patents

1 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 USP

2 Others

Filters

GEL;TOPICAL - 0.05% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons